• Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=8781440).
  
• Mutation; HGNC; HGNC:9864; RARA; Simple; p.Arg276Trp (c.826C>T); ClinVar=VCV000191350; Zygosity=Unspecified; Note=Equivalent to p.Arg611Trp in the PML-RARA fusion protein (PubMed=11438209).
  

PubMed=8781440; DOI=10.1182/blood.V88.5.1824.1824
Kizaki M., Matsushita H., Takayama N., Muto A., Ueno H., Awaya N., Kawai Y., Asou H., Kamada N., Ikeda Y.
Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features.
Blood 88:1824-1833(1996)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=11438209; DOI=10.1016/S0301-472X(01)00651-8
Takayama N., Kizaki M., Hida T., Kinjo K., Ikeda Y.
Novel mutation in the PML/RARalpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukemia.
Exp. Hematol. 29:864-872(2001)

PubMed=15234573; DOI=10.1016/j.leukres.2003.12.017
Sato A., Imaizumi M., Hoshi Y., Rikiishi T., Fujii K., Kizaki M., Kagechika H., Kakizuka A., Hayashi Y., Iinuma K.
Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene.
Leuk. Res. 28:959-967(2004)